ADAR and female reproductive organ cancer: Overall, these results demonstrate that adenosine to inosine editing is an important regulatory mechanism in the development of gynecologic cancers, and targeting this pathway, specifically ADAR1, is a promising possibility for gynecologic cancer treatment.